Novartis (NYSE: NVS) announced today changes to focus its Pharmaceuticals Division by creating two business units reporting to the CEO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE